Latest filing published 23 Apr 2026 for Day One Biopharmaceuticals, Inc.. Read the official filing
No signal scores available.
This profile gathers the share dealings of Michael Vasconcelles across 2 companies, led by Day One Biopharmaceuticals, Inc. and ImmunoGen, Inc. Over a trading history stretching from 29 December 2023 to 23 April 2026, the count stands at 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 23 April 2026: a transaction, in Day One Biopharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations